Related Experiment Video
Updated: Feb 5, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Patient-reported outcomes and quality of life measures in atopic dermatitis
Paras P Vakharia1, David Cella2, Jonathan I Silverberg3
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Abstract:
Atopic dermatitis (AD) is a complex and heterogeneous disorder with a profound symptom burden and harmful impact on multiple domains of quality of life (QOL). Many different patient-reported outcome (PRO) measures exist to assess clinical manifestations and QOL impairment in AD, but none comprehensively assess all aspects of the disease. This review addresses the PRO and QOL measures currently used in AD and their properties, strengths, weaknesses, and feasibility for assessing AD in randomized controlled trials and clinical practice. Currently, the patient-oriented eczema measure (POEM) has emerged as a preferred PRO for AD clinical manifestations, though no single instrument has developed as a preferred QOL measure. Validated PRO and QOL measures should be incorporated in all clinical trials of AD and in clinical practice where feasible.
Related Concept Videos
Half-life of a Reaction
Characteristics of Life
Data Reporting and Recording
The Angiosperm Life Cycle
Predicting Reaction Outcomes
The Tree of Life - Bacteria, Archaea, Eukaryotes

